Key statistics
As of last trade IRadimed Corp (46K:FRA) traded at 87.50, -2.23% below its 52-week high of 89.50, set on Jan 16, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 87.50 |
|---|---|
| High | 87.50 |
| Low | 87.50 |
| Bid | 88.00 |
| Offer | 89.50 |
| Previous close | 85.50 |
| Average volume | 20.00 |
|---|---|
| Shares outstanding | 12.72m |
| Free float | 8.00m |
| P/E (TTM) | 59.18 |
| Market cap | 1.32bn USD |
| EPS (TTM) | 1.75 USD |
| Annual div (ADY) | 0.6788 EUR |
|---|---|
| Annual div yield (ADY) | 0.79% |
| Div ex-date | Feb 23 2026 |
| Div pay-date | Mar 06 2026 |
Data delayed at least 15 minutes, as of Mar 02 2026 07:09 GMT.
More ▼
Announcements
- IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
- IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
- IRADIMED Announces Special Cash Dividend of $0.50 Per Share
- IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
- IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
- IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
- IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
- IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
- IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
- IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025
More ▼
